Cargando…
iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium
We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injecte...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727567/ https://www.ncbi.nlm.nih.gov/pubmed/26612359 http://dx.doi.org/10.1111/jcmm.12725 |
_version_ | 1782411984144171008 |
---|---|
author | Ja, KP Myu Mia Miao, Qingfeng Zhen Tee, Nicole Gui Lim, Sze Yun Nandihalli, Manasi J.A. Ramachandra, Chrishan Mehta, Ashish Shim, Winston |
author_facet | Ja, KP Myu Mia Miao, Qingfeng Zhen Tee, Nicole Gui Lim, Sze Yun Nandihalli, Manasi J.A. Ramachandra, Chrishan Mehta, Ashish Shim, Winston |
author_sort | Ja, KP Myu Mia |
collection | PubMed |
description | We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injected into peri‐infarcted anterior free wall. Sham‐operated animals received no injection. Myocardial function was assessed at 2‐week and 4‐week post‐infarction by using echocardiography and pressure‐volume catheterization. Early myocardial remodelling was observed at 2‐week with echocardiography derived stroke volume (SV) in saline (20.45 ± 7.36 μl, P < 0.05) and cardiomyocyte (19.52 ± 3.97 μl, P < 0.05) groups, but not in progenitor group (25.65 ± 3.61 μl), significantly deteriorated as compared to sham control group (28.41 ± 4.41 μl). Consistently, pressure–volume haemodynamic measurements showed worsening chamber dilation in saline (EDV: 23.24 ± 5.01 μl, P < 0.05; ESV: 17.08 ± 5.82 μl, P < 0.05) and cardiomyocyte (EDV: 26.45 ± 5.69 μl, P < 0.05; ESV: 18.03 ± 6.58 μl, P < 0.05) groups by 4‐week post‐infarction as compared to control (EDV: 15.26 ± 2.96 μl; ESV: 8.41 ± 2.94 μl). In contrast, cardiac progenitors (EDV: 20.09 ± 7.76 μl; ESV: 13.98 ± 6.74 μl) persistently protected chamber geometry against negative cardiac remodelling. Similarly, as compared to sham control (54.64 ± 11.37%), LV ejection fraction was preserved in progenitor group from 2‐(38.68 ± 7.34%) to 4‐week (39.56 ± 13.26%) while cardiomyocyte (36.52 ± 11.39%, P < 0.05) and saline (35.34 ± 11.86%, P < 0.05) groups deteriorated early at 2‐week. Improvements of myocardial function in the progenitor group corresponded to increased vascularization (16.12 ± 1.49/mm(2) to 25.48 ± 2.08/mm(2) myocardial tissue, P < 0.05) and coincided with augmented networking of cardiac telocytes in the interstitial space of infarcted zone. |
format | Online Article Text |
id | pubmed-4727567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47275672016-02-03 iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium Ja, KP Myu Mia Miao, Qingfeng Zhen Tee, Nicole Gui Lim, Sze Yun Nandihalli, Manasi J.A. Ramachandra, Chrishan Mehta, Ashish Shim, Winston J Cell Mol Med Original Articles We investigate the effects of myocardial transplantation of human induced pluripotent stem cell (iPSC)‐derived progenitors and cardiomyocytes into acutely infarcted myocardium in severe combined immune deficiency mice. A total of 2 × 10(5) progenitors, cardiomyocytes or cell‐free saline were injected into peri‐infarcted anterior free wall. Sham‐operated animals received no injection. Myocardial function was assessed at 2‐week and 4‐week post‐infarction by using echocardiography and pressure‐volume catheterization. Early myocardial remodelling was observed at 2‐week with echocardiography derived stroke volume (SV) in saline (20.45 ± 7.36 μl, P < 0.05) and cardiomyocyte (19.52 ± 3.97 μl, P < 0.05) groups, but not in progenitor group (25.65 ± 3.61 μl), significantly deteriorated as compared to sham control group (28.41 ± 4.41 μl). Consistently, pressure–volume haemodynamic measurements showed worsening chamber dilation in saline (EDV: 23.24 ± 5.01 μl, P < 0.05; ESV: 17.08 ± 5.82 μl, P < 0.05) and cardiomyocyte (EDV: 26.45 ± 5.69 μl, P < 0.05; ESV: 18.03 ± 6.58 μl, P < 0.05) groups by 4‐week post‐infarction as compared to control (EDV: 15.26 ± 2.96 μl; ESV: 8.41 ± 2.94 μl). In contrast, cardiac progenitors (EDV: 20.09 ± 7.76 μl; ESV: 13.98 ± 6.74 μl) persistently protected chamber geometry against negative cardiac remodelling. Similarly, as compared to sham control (54.64 ± 11.37%), LV ejection fraction was preserved in progenitor group from 2‐(38.68 ± 7.34%) to 4‐week (39.56 ± 13.26%) while cardiomyocyte (36.52 ± 11.39%, P < 0.05) and saline (35.34 ± 11.86%, P < 0.05) groups deteriorated early at 2‐week. Improvements of myocardial function in the progenitor group corresponded to increased vascularization (16.12 ± 1.49/mm(2) to 25.48 ± 2.08/mm(2) myocardial tissue, P < 0.05) and coincided with augmented networking of cardiac telocytes in the interstitial space of infarcted zone. John Wiley and Sons Inc. 2015-11-27 2016-02 /pmc/articles/PMC4727567/ /pubmed/26612359 http://dx.doi.org/10.1111/jcmm.12725 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Ja, KP Myu Mia Miao, Qingfeng Zhen Tee, Nicole Gui Lim, Sze Yun Nandihalli, Manasi J.A. Ramachandra, Chrishan Mehta, Ashish Shim, Winston iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title | iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title_full | iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title_fullStr | iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title_full_unstemmed | iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title_short | iPSC‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
title_sort | ipsc‐derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727567/ https://www.ncbi.nlm.nih.gov/pubmed/26612359 http://dx.doi.org/10.1111/jcmm.12725 |
work_keys_str_mv | AT jakpmyumia ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT miaoqingfeng ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT zhenteenicolegui ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT limszeyun ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT nandihallimanasi ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT jaramachandrachrishan ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT mehtaashish ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium AT shimwinston ipscderivedhumancardiacprogenitorcellsimproveventricularremodellingviaangiogenesisandinterstitialnetworkingofinfarctedmyocardium |